Overview
Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm with uncertain cellular lineage, often classified as having intermediate malignancy. Metastasis predominantly occurs in the lung, though intracardiac extension is exceptionally rare 1.Diagnosis
Imaging studies (CT, MRI) essential for initial assessment and detection of primary and metastatic lesions 1.
Histopathological examination required for definitive diagnosis, showing characteristic features of fibromyxoid tissue with ossification 1.
Immunohistochemistry may aid in distinguishing OFMT from other soft tissue tumors 1.Management
Primary Treatment: Wide surgical excision of the primary tumor is recommended to achieve local control 1.
Metastatic Disease: Surgical resection for resectable metastases, as illustrated in cases involving intracardiac extension 1.
Adjuvant Therapy: Radiotherapy may be considered post-surgery to reduce recurrence risk 1.
Follow-Up: Mandatory early and frequent follow-up to monitor for recurrence and metastasis 1.Special Populations
No Specific Guidance: The provided abstracts do not cover management specifics for pregnancy, pediatrics, elderly patients, or those with comorbidities 1.Key Recommendations
Perform wide surgical excision for both primary and resectable metastatic OFMT lesions to optimize outcomes (Evidence: Moderate 1).
Consider adjuvant radiotherapy following surgical resection to mitigate recurrence risk (Evidence: Moderate 1).
Implement rigorous early follow-up protocols to monitor patient status post-treatment (Evidence: Expert opinion 1).References
1 Sarraj A, Duarte J, Dominguez L, Pun YW. Resection of metastatic pulmonary lesion of ossifying fibromyxoid tumor extending into the left atrium and ventricle via pulmonary vein. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2007. link